Riskpilot← Back to searchSign inGet full accessHestetandklinikken Syd ApS
APSActiveCVR 41005750Bjellekjærvej 13Veterinary activities · NACE 7500Est. 20194 employees
Revenue 2025
DKK 3,3M
+14% vs 2024
EBITDA margin
12.0%
-20% vs 2024
Equity ratio
16.9%
Financial strength
Net profit 2025
DKK 208K
-26% vs 2024
| Revenue | DKK 3,3M | +14% |
| EBITDA | DKK 397K | -20% |
| Net profit | DKK 208K | -26% |
| Total assets | DKK 3M | +40% |
| Equity | DKK 509K | -36% |
| Employees | 4 | — |
Legal name
Hestetandklinikken Syd ApS
CVR number
41005750
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
5. december 2019
Share capital
DKK 40.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen.
Company purpose
Virksomhedens formål er at udøve dyrlægevirksomhed.
Address
Bjellekjærvej 13
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1.279 | 1.647 | 1.967 | 2.718 | 2.900 | 3.313 |
| Staff expenses | -652 | -737 | -1.759 | -2.106 | -2.407 | -2.916 |
| EBITDA | 627 | 910 | 208 | 613 | 493 | 397 |
| Depreciation & amort. | -17 | -83 | -88 | -107 | -132 | -131 |
| EBIT | 610 | 827 | 120 | 506 | 361 | 265 |
| Net financials | -1 | -7 | -11 | -0 | 3 | 1 |
| Profit before tax | 609 | 820 | 109 | 506 | 365 | 267 |
| Tax | 134 | 180 | 25 | 111 | 83 | 58 |
| Net profit | 475 | 640 | 84 | 395 | 282 | 208 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 1.121 | 1.238 | 737 | 1.618 | 2.137 | 3.001 |
| Equity | 515 | 680 | 124 | 519 | 801 | 509 |
| Long-term debt | 46 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 558 | 553 | 610 | 1.099 | 1.337 | 2.493 |
| Total debt | 604 | 553 | 610 | 1.099 | 1.337 | 2.493 |
EBITDA margin
12.0%
This company
15.8%
Market median
-24% vs market
20202025
Equity ratio
16.9%
This company
38.2%
Market median
-56% vs market
20202025
Return on equity
40.9%
This company
18.4%
Market median
+122% vs market
20202025
Net profit margin
6.3%
This company
8.1%
Market median
-22% vs market
20202025
Asset turnover
1.10×
This company
1.12×
Market median
+2% vs market
20202025
Debt / equity
4.90×
This company
0.62×
Market median
-690% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-12-05 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JG Management | Management | 2019 | — | — |
AH Management | Management | 2019 | — | — |
NB Management | Management | 2021 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Altano Denmark A/S | Company | 66.7% | 66.7% | 2022 |
Hestetandklinikken ApS | Company | 33.3% | 33.3% | 2021 |
Nicolaj Bach Holding ApS | Company | 66.7% | 66.7% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Altano Denmark A/S
Hestetandklinikken Syd ApS Board members of Hestetandklinikken Syd ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Grud Rosenmeier | Management | 0 companies |
| Anders Hein Christiansen | Management | 0 companies |
| Nicolaj Bach Sørensen | Management | 0 companies |